These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11123497)

  • 1. Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro-in vivo evaluation.
    Dogru ST; Calis S; Oner F
    J Clin Pharm Ther; 2000 Dec; 25(6):435-43. PubMed ID: 11123497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo preclinical evaluation of a minisphere emulsion-based formulation (SmPill®) of salmon calcitonin.
    Aguirre TA; Rosa M; Coulter IS; Brayden DJ
    Eur J Pharm Sci; 2015 Nov; 79():102-11. PubMed ID: 26349051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
    Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
    Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage.
    Aguirre TAS; Aversa V; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
    J Control Release; 2016 Sep; 238():242-252. PubMed ID: 27480451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats.
    Wu L; Zhang G; Lu Q; Sun Q; Wang M; Li N; Gao Z; Sun Y; Li T; Han D; Yu X; Wang L; Sun W; Zhao D; Wu Y; Lu Y; Chen X
    Drug Dev Ind Pharm; 2010 Mar; 36(3):362-70. PubMed ID: 19719396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
    Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on pulmonary delivery of salmon calcitonin in rats: effects of protease inhibitors and absorption enhancers.
    Kobayashi S; Kondo S; Juni K
    Pharm Res; 1994 Sep; 11(9):1239-43. PubMed ID: 7816750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous/nanoparticulate microparticles (NPMPs) for inhalation.
    Amaro MI; Tewes F; Gobbo O; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
    Int J Pharm; 2015 Apr; 483(1-2):6-18. PubMed ID: 25660067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes.
    Cho W; Kim MS; Jung MS; Park J; Cha KH; Kim JS; Park HJ; Alhalaweh A; Velaga SP; Hwang SJ
    Int J Pharm; 2015 Jan; 478(1):288-296. PubMed ID: 25445994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of protease inhibitors on pulmonary bioavailability of therapeutic proteins and peptides in the rat.
    Amancha KP; Hussain A
    Eur J Pharm Sci; 2015 Feb; 68():1-10. PubMed ID: 25460544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flash Fabrication of Orally Targeted Nanocomplexes for Improved Transport of Salmon Calcitonin across the Intestine.
    Sun L; Le Z; He S; Liu J; Liu L; Leong KW; Mao HQ; Liu Z; Chen Y
    Mol Pharm; 2020 Mar; 17(3):757-768. PubMed ID: 32011888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible lipidization for the oral delivery of salmon calcitonin.
    Wang J; Chow D; Heiati H; Shen WC
    J Control Release; 2003 Mar; 88(3):369-80. PubMed ID: 12644363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
    Liu L; Yang H; Lou Y; Wu JY; Miao J; Lu XY; Gao JQ
    Int J Pharm; 2019 Feb; 557():170-177. PubMed ID: 30597264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved intestinal delivery of salmon calcitonin by water-in-oil microemulsions.
    Fan Y; Li X; Zhou Y; Fan C; Wang X; Huang Y; Liu Y
    Int J Pharm; 2011 Sep; 416(1):323-30. PubMed ID: 21726618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional differences in intestinal spreading and pH recovery and the impact on salmon calcitonin absorption in dogs.
    Lee YH; Perry BA; Sutyak JP; Stern W; Sinko PJ
    Pharm Res; 2000 Mar; 17(3):284-90. PubMed ID: 10801216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery.
    Lee HE; Lee MJ; Park CR; Kim AY; Chun KH; Hwang HJ; Oh DH; Jeon SO; Kang JS; Jung TS; Choi GJ; Lee S
    J Control Release; 2010 Apr; 143(2):251-7. PubMed ID: 20026364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
    du Plessis LH; Lubbe J; Strauss T; Kotzé AF
    Int J Pharm; 2010 Jan; 385(1-2):181-6. PubMed ID: 19854253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of reversible and nonreversible aqueous-soluble lipidized conjugates of salmon calcitonin.
    Cheng W; Lim LY
    Mol Pharm; 2008; 5(4):610-21. PubMed ID: 18481870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of salmon calcitonin using a microneedle patch.
    Tas C; Mansoor S; Kalluri H; Zarnitsyn VG; Choi SO; Banga AK; Prausnitz MR
    Int J Pharm; 2012 Feb; 423(2):257-63. PubMed ID: 22172290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process and formulation variables of pregabalin microspheres prepared by w/o/o double emulsion solvent diffusion method and their clinical application by animal modeling studies.
    Aydogan E; Comoglu T; Pehlivanoglu B; Dogan M; Comoglu S; Dogan A; Basci N
    Drug Dev Ind Pharm; 2015; 41(8):1311-20. PubMed ID: 25119000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.